Our Team - H&B JISHI

Prof.Zhong Chao HAN

Ph.D.. Occidental Bretagne University, Brest. France ( 1986 )

Director of Lab. Institute of Blood and Vessels, Paris (1990-1996)

Professor, University Paris VII (1996-1997)

Professor of Hematology,CAMS & PUMC (1997-present)

Director of the Institute of Hematology & Hospital of Blood Diseases, CAMS & PUMC (1997-2004)

Director of the National Engineering Research Center of Cell Products, China (2005-present)

Corresponding member of French National Academy of Medicine(2006)

Member of French National Academy of Technologies (2014)

Grade d'officeir national de la Legion d'honneur de France (2016).

Excellence visiting professor of Lorraine University (2017-2021)

Founder and President of H&B Group (2007-present)

More than 600 papers published in peer reviewed journals including Lancet. Nature Med. Nature Comm, Blood and Biomaterials.

40 scientific and technology awards

Jacaues CAEN

French Academy of Technologies

French Academia of Sciences

French Academia of Medicine

Chinese Academy of Engineering

Chinese Government Friendship Award

China International Science and Technology Cooperation Award

Corporate shareholder

Georges UZAN

French Academia of Medicine

Chinese Government Friendship Award

Corporate shareholder

CTO of H&B France

Expert on Stem cells

Jean-Pierre Cazanave

French Academia of Medicine

Corporate shareholder

President of Strategy Committee

Expert on biotechnology

JPatrick Squiban

MD, CEO H&B France
30+ years as Executive Vice President Medical and Regulatory Affairs or Chief Medical Officer in pharmaceutical and biotech companies Boerhinger Ingelheim (Reims), Innate-Pharma (Marseille) , Transgene (Strasbourg), Novo Nordisk , Zymogenetics (Seattle), Patrick was also Business Angels and Ambassador of the Angels Sante Business Angels Investment network.

Pr Jean-Francois Rossi

MD PhD, CMO, H&B France
Emeritus Professor of Hematology (University of Montpellier), certified in Rheumatology, Immunology, Internal Medicine, Medical Oncology and Hematology, with more than 200 publications - AACR award in 2017. Member of different international scientific societies and co-founders of 3 start-ups.

Gilles Avenard

MD CEO & Chairman of the Board of Acticor Biotech
Board member or advisor for several biotech companies: co-founder and COO of BioAlliance Pharma SA —ONXEO (NYS RONEXT) uMil 2010. Gilles Avenard was involved in the development of several innovative medicin until their registration in Euro, and the USA. Before that, he was Projects Director for Hoechst Madan Roussel (Sanofi) and Medical Director of Bio-Transfusion (LOB).

Pr Jean-Pierre Cazenave

Chairman of the Strategic Committee
Honorary Professor of Hematology and Transfusion (University of Strasbourg), President of ARMESA, at Strasbourg medical research Association and member of the French Academie Nationale de Medecine. Former Director of the Blood Transfusion Center of EFS-Alsace in Strasbourg. Member of several international medical societies, and author of more than 600 scientific publications.

Cecile Cleach

Research Engineer
Master recherche Biologie Sante Ecologie Signalisation et systemes integres en biologie (EPHE Paris 2012-2013) Licence Professionnelle de Genomique ENCPB Paris 2010-2011

Océan Caen

Business Development & communication
Studied Chinese and International business at the Beijing Language and Cultural University from 2008 to 2012. Graduated in 2016 in International Marketing and Business Development at Skema Business School (Paris). Ocean performed several internships and missions at Beijing H&B , Laboratoires Servier, Aeroports de Paris and La Francaise des Jeux.

Zhibo Han